Wells Fargo & Company Forecasts Strong Price Appreciation for Hamilton Lane (NASDAQ:HLNE) Stock

Hamilton Lane (NASDAQ:HLNE) had its price objective raised by equities research analysts at Wells Fargo & Company from $163.00 to $169.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential downside of 0.47% from the company’s previous close.

HLNE has been the topic of several other research reports. The Goldman Sachs Group cut shares of Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price objective on the stock. in a research note on Monday, January 6th. Morgan Stanley upped their price target on Hamilton Lane from $182.00 to $190.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. JPMorgan Chase & Co. raised their price objective on Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. UBS Group lifted their price objective on Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 22nd. Finally, Oppenheimer raised shares of Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 target price for the company in a research report on Tuesday, January 21st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, Hamilton Lane currently has an average rating of “Hold” and a consensus price target of $171.71.

Hamilton Lane Price Performance

HLNE traded up $8.40 on Wednesday, reaching $169.80. The stock had a trading volume of 147,481 shares, compared to its average volume of 397,202. The firm has a 50-day moving average of $160.49 and a 200-day moving average of $162.75. Hamilton Lane has a fifty-two week low of $103.42 and a fifty-two week high of $203.72. The company has a market capitalization of $9.41 billion, a price-to-earnings ratio of 36.76 and a beta of 1.25. The company has a current ratio of 3.37, a quick ratio of 3.37 and a debt-to-equity ratio of 0.24.

Hamilton Lane (NASDAQ:HLNE) last issued its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.12. Hamilton Lane had a net margin of 28.03% and a return on equity of 35.59%. The business had revenue of $168.26 million during the quarter, compared to analyst estimates of $158.86 million. During the same quarter last year, the business earned $0.71 EPS. The firm’s quarterly revenue was up 34.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Hamilton Lane will post 4.88 EPS for the current year.

Institutional Trading of Hamilton Lane

Several large investors have recently modified their holdings of HLNE. AQR Capital Management LLC boosted its stake in Hamilton Lane by 3.7% during the second quarter. AQR Capital Management LLC now owns 8,979 shares of the company’s stock worth $1,110,000 after acquiring an additional 322 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Hamilton Lane by 8.4% during the second quarter. The Manufacturers Life Insurance Company now owns 23,265 shares of the company’s stock valued at $2,875,000 after purchasing an additional 1,810 shares during the period. Truist Financial Corp boosted its position in shares of Hamilton Lane by 6.8% during the 2nd quarter. Truist Financial Corp now owns 12,477 shares of the company’s stock worth $1,542,000 after purchasing an additional 790 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Hamilton Lane during the 2nd quarter worth about $824,000. Finally, Handelsbanken Fonder AB grew its stake in shares of Hamilton Lane by 75.4% in the 3rd quarter. Handelsbanken Fonder AB now owns 11,400 shares of the company’s stock valued at $1,920,000 after buying an additional 4,900 shares during the period. Institutional investors and hedge funds own 97.40% of the company’s stock.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.